3 employees
Novel paradigm-shifting vaccines with emphasis on cellular immunity
2018
$1.4M
from 2 investors over 2 rounds
Belyntic GmbH raised $1.4M on September 17, 2019
Investors: High-Tech Gründerfonds and Investitionsbank Berlin